1420 related articles for article (PubMed ID: 17310783)
1. [Application and problems of quantiFERON TB-2G for tuberculosis control programs--(2) clinical use of quantiFERON TB-2G].
Kawabe Y
Kekkaku; 2007 Jan; 82(1):61-6. PubMed ID: 17310783
[TBL] [Abstract][Full Text] [Related]
2. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
Harada N
Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
[TBL] [Abstract][Full Text] [Related]
4. [Application and problems of quantiFERON TB-2G for tuberculosis control programs--(1) tuberculosis outbreak in a Cram School].
Fukazawa K
Kekkaku; 2007 Jan; 82(1):53-9. PubMed ID: 17310782
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of a novel diagnostic method of tuberculosis infection, QuantiFERON TB-2G, in an outbreak of tuberculosis].
Harada N; Mori T; Shishido S; Higuchi K; Sekiya Y
Kekkaku; 2004 Nov; 79(11):637-43. PubMed ID: 15729888
[TBL] [Abstract][Full Text] [Related]
6. [Usefulness of QuantiFERON TB-2G in contact investigation of a tuberculosis outbreak in a university].
Funayama K; Tsujimoto A; Mori M; Yamamoto H; Fujiwara K; Nishimura T; Hasegawa N; Horiguchi I; Mori T; Marui E
Kekkaku; 2005 Jul; 80(7):527-34. PubMed ID: 16167779
[TBL] [Abstract][Full Text] [Related]
7. [Detection of tuberculosis infection using a whole blood interferon gamma assay in a contact investigation--evaluation using quantiFERon TB-2G].
Miyashita H; Higuchi K; Higashiyama N; Oki S; Harada N; Sekiya Y; Shishido S; Mori T
Kekkaku; 2005 Aug; 80(8):557-64. PubMed ID: 16218445
[TBL] [Abstract][Full Text] [Related]
8. Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis.
Kobashi Y; Obase Y; Fukuda M; Yoshida K; Miyashita N; Oka M
Clin Infect Dis; 2006 Dec; 43(12):1540-6. PubMed ID: 17109285
[TBL] [Abstract][Full Text] [Related]
9. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
Sato S; Nagai H
Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of the QuantiFERON-TB Gold test in patients with non-tuberculous mycobacterial disease.
Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Okimoto N; Matsushima T; Kageoka T; Oka M
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1422-6. PubMed ID: 19861017
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of tuberculosis infection among foreigners using QuantiFeron TB-2G test].
Higuchi K; Harada N; Nagasaka Y; Mori T
Kekkaku; 2007 Jun; 82(6):515-21. PubMed ID: 17633119
[TBL] [Abstract][Full Text] [Related]
12. [Usefulness of a whole blood interferon gamma assay (QuantiFERON-TB-2G) for detecting tuberculosis infection in HIV-infected persons].
Nagai H; Kawabe Y; Ariga H; Shigiyama F; Shimada M; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ooshima N; Masuda K; Matsui H; Tamura A; Nagayama N; Akagawa S; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2007 Aug; 82(8):635-40. PubMed ID: 17874571
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing tuberculosis from Mycobacterium avium complex disease using an interferon-gamma release assay.
Ra SW; Lyu J; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
Int J Tuberc Lung Dis; 2011 May; 15(5):635-40. PubMed ID: 21756514
[TBL] [Abstract][Full Text] [Related]
14. [Outbreak of pulmonary tuberculosis in which tuberculosis developed from QuantiFERON-TB second generation (QFT-2G) test negative persons].
Yamaguchi J; Ooba Y; Kaneda M; Uchida K; Ishikawa Y; Suzuki K; Yagi T; Sasaki Y; Yamagishi F
Kekkaku; 2007 Aug; 82(8):629-34. PubMed ID: 17874570
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of a T cell-based assay in the diagnosis of extrapulmonary tuberculosis.
Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Oka M
Respirology; 2009 Mar; 14(2):276-81. PubMed ID: 19210655
[TBL] [Abstract][Full Text] [Related]
16. [Effects of prophylaxis on QuantiFERON TB-2G responses among children].
Higuchi K; Okada K; Harada N; Mori T
Kekkaku; 2008 Sep; 83(9):603-9. PubMed ID: 18979994
[TBL] [Abstract][Full Text] [Related]
17. [Lessons learned from tuberculosis outbreak cases].
Kato S; Kuwabara K
Kekkaku; 2014 Feb; 89(2):77-88. PubMed ID: 24716362
[TBL] [Abstract][Full Text] [Related]
18. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons.
Diel R; Nienhaus A; Lange C; Meywald-Walter K; Forssbohm M; Schaberg T
Respir Res; 2006 May; 7(1):77. PubMed ID: 16707012
[TBL] [Abstract][Full Text] [Related]
19. Agreement between Mantoux skin testing and QuantiFERON-TB assay using dual mycobacterial antigens in current and former injection drug users.
Shah SS; McGowan JP; Klein RS; Converse PJ; Blum S; Gourevitch MN
Med Sci Monit; 2006 Apr; 12(4):MT11-6. PubMed ID: 16572060
[TBL] [Abstract][Full Text] [Related]
20. [Cost-effectiveness analysis of QuantiFERON-TB 2nd generation used for detection of tuberculosis infection in contact investigations].
Mori T; Harada N
Kekkaku; 2005 Nov; 80(11):675-86. PubMed ID: 16363672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
